Clinical trialNCT06532058RecruitingPhase 2Interventional

Phase IIa Study to Assess Safety and Efficacy in the Relapsed/Refractory Acute Myeloid Leukemia

SponsorChangzhou Qianhong Bio-pharma Co., Ltd.Enrollment53Relapsed/Refractory Acute Myeloid Leukemia (R/R-AML)

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Li Junmin, Doctor
Ruijin Hospital
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

China

Henan Cancer Hospital
Zhengzhou, Henan, China
Zhang Yanli, Doctor
Recruiting
Zhongnan Hospital of Wuhan University
Wuhan, Hubei, China
Zhou Fuling, doctor
Recruiting
the First People'S Hospital of Changzhou
Changzhou, Jiangsu, China
Gu Weiying, doctor
Recruiting
Huai 'An First People'S Hospital
Huaian, Jiangsu, China
Wang Chunling, Doctor
Recruiting
Jiangsu Province Hospital
Nanjing, Jiangsu, China
Qian Sixuan, Doctor
Recruiting
Zhongda Hospital
Nanjing, Jiangsu, China
Ge Zheng, Doctor
Recruiting
Shengjing Hospital
Shenyang, Liaoning, China
Yang Wei, doctor
Recruiting
Qilu Hospital of Shandong University
Jinan, Shangdong, China
Ji Min, doctor
Recruiting
Ruijin Hospitol
Shanghai, Shanghai Municipality, China
Recruiting
Tongren Hospital Shanghai Jiao Tong University School of Medicine
Shanghai, Shanghai Municipality, China
Liu Ligen, doctor
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 10 Aug 2023
Primary completion: 10 Feb 2025
Completion: 10 May 2025
Last update posted: 1 Aug 2024
Registered enrollment: 53
Registry id: NCT06532058

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.